IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype

  • Etude concernée: 0401-EPIDEMIO
  • Auteurs / Authors: Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, Morere JF, Souquet PJ, Soria JC, Morin F, Milleron B; IFCT-0401 Trial Group
  • Journal / Conference: Journal of Thoracic Oncology
  • Année / Year: 2009
  • PMID: 19574932
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/19574932